AstraZeneca Nexium Marketing Draws FTC Scrutiny; DoJ Looking At Prilosec
Executive Summary
The Federal Trade Commission is investigating AstraZeneca's marketing of the omeprazole follow-on product Nexium
You may also be interested in...
AstraZeneca subpoenaed
The Boston U.S. Attorney's office issues subpoena to AstraZeneca as part of an investigation related to sales and marketing practices to a physician's office in Worcester, Mass., company says in a Securities & Exchange Commission 1filing. This investigation is separate from another Boston U.S. Attorney investigation into Prilosec promotions to New England Medical Center (2"The Pink Sheet" March 3, 2003, p. 3)...
AstraZeneca subpoenaed
The Boston U.S. Attorney's office issues subpoena to AstraZeneca as part of an investigation related to sales and marketing practices to a physician's office in Worcester, Mass., company says in a Securities & Exchange Commission 1filing. This investigation is separate from another Boston U.S. Attorney investigation into Prilosec promotions to New England Medical Center (2"The Pink Sheet" March 3, 2003, p. 3)...
Nexium-Style Products Encourage Price Competition, FDA’s McClellan Says
The availability of follow-on products like AstraZeneca's Nexium can encourage price competition within a therapeutic class, FDA Commissioner McClellan told the National Press Club Aug. 8 in Washington, D.C